Primary stenting for atherosclerotic renal artery stenosis

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Interventional Radiology

Background:

• Atherosclerotic renal artery stenosis (ARAS) is a significant condition impacting renal function.
• Endovascular treatment, particularly stenting, has seen increased use for ARAS over the past three decades.
• Recent large randomized trials have provided critical data on the clinical benefits of ARAS interventions.

Purpose of the Study:

• To systematically review controlled studies evaluating primary stenting for atherosclerotic renal artery stenosis.
• To compare the outcomes of stenting versus other treatments for ARAS.
• To assess the impact of different stent characteristics and stenting methods on ARAS outcomes.

Main Methods:

• Systematic review of controlled studies on primary stenting for ARAS.
• Inclusion criteria focused on comparisons between stenting and other treatments or variations in stenting techniques.
• Analysis of outcomes related to revascularization strategies for atherosclerotic renal artery stenosis.

Main Results:

• Stenting is favored over angioplasty alone and surgery for ostial ARAS when revascularization is indicated, barring coexistent aortic disease requiring surgery.
• Randomized trials found no significant benefit of renal artery stenting over medication alone for ARAS patients lacking compelling indications, with notable risks.
• Procedural enhancements like embolic protection devices and coated stents did not correlate with improved clinical outcomes in ARAS stenting.

Conclusions:

• Impaired renal function in ARAS appears more stable than previously thought.
• Optimal medical treatment is the primary recommendation for the majority of ARAS patients.
• Compelling indications for ARAS revascularization, such as rapidly progressive renal failure or hypertension, are supported by limited evidence.